|
PRESS
RELEASE
CONTACT INFORMATION:
Brad Bullen
(781) 894-0800
bbullen@novabio.com
FOR IMMEDIATE RELEASE
Nova Biomedical awarded Blood Gas Analyzer
agreement with Premier, Inc.
 Waltham,
MA – Nova Biomedical announced today that it has been
awarded a group purchasing agreement with Premier, Inc., for
its Blood Gas
Analyzer
category. EFFECTIVE October 1, 2014, the new agreement
allows Premier members, at their discretion, to take
advantage of special pricing and terms pre-negotiated by
Premier for Nova Stat Profile Prime and pHOx Ultra analyzers
and associated consumables.
“We at Nova Biomedical are extremely excited to make
available our latest blood gas platform, the Stat Profile
Prime CCS or critical care system, to the Premier
membership, in addition to our comprehensive 20-test Stat
Profile pHOx Ultra analyzer. Stat Profile Prime represents
the latest critical care testing technology and further
demonstrates Nova’s leadership and history of innovation,”
said Brad Bullen, Sales Product Line Manager - Core
Products, at Nova. “Prime’s zero maintenance system allows
users to focus on what is important—patient care.”
Stat Profile Prime’s ZERØ™ maintenance cartridge technology
consists of individual cartridges for biosensors,
calibrators, and liquid quality control. Each cartridge is
maintenance-free, ready to use, and easily replaced in
seconds. This design optimizes the life of each cartridge;
improves analyzer uptime; and eliminates the waste,
downtime, and higher costs of older combined
calibrator/sensor cartridge systems.
Nova’s new technology MicroSensor Card contains biosensors
for pH, PCO2, PO2, Na, K, iCa, Cl, Glu, and Lac. Credit
card-sized, the MicroSensor Card is automatically calibrated
and always ready to deliver a full 10-test profile in just
60 seconds. MicroSensor cards can be replaced in less than
half the time of older cartridge systems, which can take
more than one hour to calibrate and can remain unstable with
drift, frequent re-calibrations, and reduced throughput for
even longer periods of time.
About Premier, Inc.
Premier, Inc. is a leading healthcare
improvement company, uniting an alliance of approximately
3,000 U.S. hospitals and 110,000 other providers to
transform healthcare. With integrated data and analytics,
collaboratives, supply chain solutions, and advisory and
other services, Premier enables better care and outcomes at
a lower cost. Premier, a Malcolm Baldrige National Quality
Award recipient, plays a critical role in the rapidly
evolving healthcare industry, collaborating with members to
co-develop long-term innovations that reinvent and improve
the way care is delivered to patients nationwide.
Headquartered in Charlotte, N.C., Premier is passionate
about transforming American healthcare. Please visit
Premier’s news and investor sites on www.premierinc.com;
as well as
Twitter,
Facebook,
LinkedIn,
YouTube,
Instagram,
Foursquare
and
Premier’s blog for
more information about the company.
About Nova Biomedical
Incorporated in 1976 and based in Waltham,
MA, Nova Biomedical is a world leader in the development and
manufacturing of state-of-the-art whole blood analyzers for
point of care and critical care testing. Nova is one of the
fastest growing in vitro diagnostic companies in the world.
Nova’s whole blood biosensor technology is incorporated in
products ranging from handheld meters for glucose self- and
point-of-care testing to critical care whole blood analyzers
designed for rapid measurement of over 20 analytes. Nova
sales and service operations are worldwide with local
subsidiaries or distributors in 100 countries, and wholly
owned subsidiaries located in Canada, France, Germany, Great
Britain, and Japan. Certified by the International
Organization for Standardization, Nova’s state-of-the-art
manufacturing operations are and located in the U.S. and
abroad.
www.novabiomedical.com
# # #
|
